Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that acts as a neurotransmitter in the brain and in the autonomic nervous system. In the autonomic system it is produced mainly by neurons of the sympathetic nervous system and serves as a strong vasoconstrictor and also causes growth of fat tissue. In the brain, it is produced in various locations including the hypothalamus, and is thought to have several functions, including increasing food intake and storage of energy as fat, reducing anxiety and stress, reducing pain perception, affecting the circadian rhythm, reducing voluntary alcohol intake, lowering blood pressure and controlling epileptic seizures.
Neuropeptide Y (human, rat) Acetate is a highly conserved, 36-amino acid peptide found abundantly in the central and peripheral nervous systems of mammals, including both humans and rodents. As a member of the pancreatic polypeptide family, Neuropeptide Y (NPY) plays a pivotal role in modulating a broad spectrum of physiological processes, particularly those related to neuroendocrine signaling, energy homeostasis, and stress responses. Its widespread distribution and multifaceted biological activity make it a critical molecule for researchers exploring neuronal communication, metabolic regulation, and neuropeptide receptor interactions. The acetate form is favored in biochemical studies for its stability and compatibility with a variety of assay systems, supporting advanced research into peptide function and signaling dynamics.
Neuroscience research: NPY is extensively utilized in neurobiological investigations to elucidate mechanisms of synaptic transmission, neuronal excitability, and neuropeptide-mediated modulation within the brain. Experimental models employing this peptide help clarify its role in regulating appetite, circadian rhythms, anxiety, and stress adaptation. By applying NPY to neuronal cultures or brain slices, researchers can dissect its receptor-specific actions, signaling pathways, and effects on neurotransmitter release, thereby advancing understanding of neural circuit function and plasticity.
Metabolic studies: The peptide is instrumental in research focused on energy balance and metabolic regulation. It serves as a potent tool for probing hypothalamic pathways that control feeding behavior, energy expenditure, and adiposity. Experimental administration of NPY in animal models or cellular systems enables detailed analysis of its influence on appetite stimulation, insulin secretion, and lipid metabolism. These studies provide valuable insights into the neuroendocrine control of body weight and the pathophysiology of metabolic disorders.
Receptor pharmacology: Neuropeptide Y is widely employed in receptor binding assays and signal transduction studies aimed at characterizing Y receptor subtypes (Y1, Y2, Y4, Y5, and Y6) and their downstream effectors. Through competitive binding experiments, second messenger analyses, and functional assays, researchers can delineate receptor selectivity, ligand affinity, and structure-activity relationships. Such investigations are essential for the development of selective receptor modulators and for mapping the distribution and physiological roles of NPY receptors in various tissues.
Peptide structure-function analysis: The availability of synthetic NPY facilitates systematic exploration of structure-activity relationships using analogs, fragments, or modified derivatives. By substituting specific amino acids or altering peptide termini, scientists can identify critical residues responsible for biological activity, receptor interaction, or resistance to enzymatic degradation. These studies underpin rational peptide design and the development of novel research tools for dissecting neuropeptide signaling.
Analytical method development: NPY is frequently used as a standard or reference compound in the optimization and validation of analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and immunoassays. Its defined sequence and stable properties make it suitable for calibrating detection systems, quantifying endogenous peptide levels, and ensuring assay reproducibility. Reliable analytical methods supported by NPY standards are fundamental for accurate measurement of neuropeptide concentrations in biological samples and for quality control in peptide research.
Stress is defined as an adverse condition that disturbs the homeostasis of the body and activates adaptation responses. Among the many pathways and mediators involved, neuropeptide Y (NPY) stands out due to its unique stress-relieving, anxiolytic and neuroprotective properties. Stress exposure alters the biosynthesis of NPY in distinct brain regions, the magnitude and direction of this effect varying with the duration and type of stress. NPY is expressed in particular neurons of the brainstem, hypothalamus and limbic system, which explains why NPY has an impact on stress-related changes in emotional-affective behaviour and feeding as well as on stress coping. The biological actions of NPY in mammals are mediated by the Y1, Y2, Y4 and Y5 receptor, Y1 receptor stimulation being anxiolytic whereas Y2 receptor activation is anxiogenic. Emerging evidence attributes NPY a role in stress resilience, the ability to cope with stress. Thus there is a negative correlation between stress-induced behavioural disruption and cerebral NPY expression in animal models of post-traumatic stress disorder. Exogenous NPY prevents the negative consequences of stress, and polymorphisms of the NPY gene are predictive of impaired stress processing and increased risk of neuropsychiatric diseases. Stress is also a factor contributing to, and resulting from, neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease, in which NPY appears to play an important neuroprotective role. This review summarizes the evidence for an implication of NPY in stress-related and neurodegenerative pathologies and addresses the cerebral NPY system as a therapeutic target.
Reichmann, F., & Holzer, P. (2016). Neuropeptide Y: a stressful review. Neuropeptides, 55, 99-109.
Neuropeptide Y (NPY) is widely distributed in the human body and contributes to a vast number of physiological processes. Since its discovery, NPY has been implicated in metabolic regulation and, although interest in its role in central mechanisms related to food intake and obesity has somewhat diminished, the topic remains a strong focus of research concerning NPY signalling. In addition, a number of other uses for modulators of NPY receptors have been implied in a range of diseases, although the development of NPY receptor ligands has been slow, with no clinically approved receptor therapeutics currently available. Nevertheless, several interesting small molecule compounds, notably Y2 receptor antagonists, have been published recently, fueling optimism in the field. Herein we review the role of NPY in the pathophysiology of a number of diseases and highlight instances where NPY receptor signalling systems are attractive therapeutic targets.
Brothers, S. P., & Wahlestedt, C. (2010). Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO molecular medicine, 2(11), 429-439.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More